Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron Isomaltoside in Colorectal Cancer Surgery
NCT03565354Phase 3Completed
- Sponsor
- Prince of Wales Hospital
- Start
- Jul 2018
- Primary completion
- Jun 2020
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Prince of Wales Hospital. Started Jul 2018; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03565354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565354.